Sterbende sedieren?

Zusammenfassung

Sedierung bei Schwerstkranken und Sterbenden spielt eine zunehmende Rolle zur Behandlung therapierefraktärer Symptome aber auch zur Minderung von Anspannung und Angst in der Sterbebegleitung. Im Zusammenhang mit der auch in Deutschland zunehmenden Selbstbestimmungs- und Euthanasiedebatte wird auch das Thema einer „terminalen Sedierung” kontrovers diskutiert. Die Berücksichtigung individueller Bedürfnisse, aber auch die Möglichkeit des Missbrauchs einer „terminalen Sedierung” zur vorzeitigen Lebensbeendigung machen es notwendig, Indikationen, Ziele, Absichten und ethische Implikationen einer medikamentösen Sedierung am Lebensende kritisch zu reflektieren und ihren Stellenwert anhand von Richtlinien zu verdeutlichen.

Summary

Sedation in the final stages of life plays an increasing role to control refractory physical and psychological symptoms and to diminish distress and anxiety in palliative care. In the debate on euthanasia and self determination also in Germany the issue of „terminal sedation” has evoked ethical concerns and is discussed controversially. With respect for personal needs the intentions, aims and indications for medical sedation should be carefully reflected under ethical aspects to clarify its position in end-of-life care

Literatur

• 1 Billings J A, Block S D. Slow Euthanasia.  J Palliative Care. 1996;  12 21-30
• 2 Blocher M B. The Ethics of Terminal Sedation as a Treatment of End-of-Life Pain and Suffering.  Biblical Bioethics. 2003;  7 1-4
• 3 Broeckaert B, NunezOlarte J M. Sedation in palliative care: facts and concepts. Buckingham: Open University Press In: ten Have H, Clark D, eds. The ethics of palliative care: European perspectives. Facing Death series 2002: 166-180
• 4 Byock I R. When suffering persists.  J Palliat Care. 1994;  10 8-13
• 5 Caraceni A. et al .Terminal Sedation: A retrospective survey of a three-year experience. www.eapcnet.org/download/forLyon2002/ selectedab-stracts/242_Caraceni.pdf
• 6 Chater  S, Viola R, Paterson J. Jarvis: Sedation for intractable distress in the dying - a survey of experts.  Pall Med. 1998;  12 255-269
• 7 Cherny N I, Portenoy R K. Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment.  J Palliat Care. 1994;  10 31-38
• 8 Chiu T Y, Hu W Y, Lue B H, Cheng S Y, Chen C Y. Sedation for refractory symptoms of terminal cancer patients in Taiwan.  J Pain Symp Manage. 2001;  21 467-472
• 9 Cowan J D, Palmer T W. Practical guide to palliative sedation.  Curr Oncol Rep. 2002;  4 242-249
• 10 Cowan J D, Walsh D. Terminal sedation in palliative medicine - definition and review of the literature.  Support Care Cancer. 2001;  9 403-407
• 11 Craig G. Terminal sedation. CMQ www.catholicdoctors.org.uk/CMQ/ Feb_2002/termi-nal_sedation.htm 2002
• 12 Dahlkamp J. et al . Tiefschlaf bis zum Tod.  Der Spiegel. 2003;  41 206-208
• 13 Enck R E. Drug induced terminal sedation for symptom control.  Am J Hospice Palliat Care. 1991;  8 3-5
• 14 Fainsinger R L, Waller A. et al . A multicentre inter-national study of sedation for uncontrolled symptoms in terminally ill patients.  Pall Med. 2000;  14 257-265
• 15 Førde R, Olaf G, Aasland O G, Falkum E, Breivik H, Kaasa S. Palliative sedation to the dying patient.  Tidsskr Nor Lægeforen. 2001;  121 1085-1088
• 16 Furst C J, Hagenfeldt K. End-of-life sedation - definition and clinical guidelines needed.  Lakartidningen. 2002;  99 3830-3835
• 17 Goldstein-Shirley J, Fine P G. „Ethics of Total Sedation” Total Sedation Educational Resources Draft, prepared by a Task Force of the NHPCO. Ethics Committee (Session 8A, March 25, 2001) 1-10
• 18 Hallenbeck J L. Terminal Sedation: Ethical Implications in Different Situations.  J of Pall Med. 2000;  3 313-320
• 19 Hawryluck L A, Harvey W RC. et al . Consensus guidelines on analgesia and sedation in dying intensive care unit patients.  BMC Medical Ethics. 2002;  3 3
• 20 Hinkka H, Kosunen E. et al . Decision making in terminal care: a survey of Finnish doctor’s treatment decisions in end-of-life scenarios involving a terminal cancer and a terminal dementia patient.  Pall Med. 2002;  16 195-204
• 21 Irwin M. Terminal Sedation. Voluntary Euthanasia News 2001: 8-9
• 22 Jansen L A, Sulmasy D P. Sedation, alimentation, hydration, and equivocation: careful conversation about care at the end of life.  Ann Intern Med. 2002;  136 845-849
• 23 Jonas H. Philosophical Essays: From Ancient Creed to Technological Man. Englewood Cliffs, NJ: Prentice-Hall 1974: 130
• 24 v. Kolfschooten F . Dutch television report stirs up euthanasia controversy.  Lancet. 2003;  361 1352-1353
• 25 Krakauer E L, Penson R T. et al . Sedation for intractable distress of a dying patient.  The Oncologist. 2000;  5 53 62
• 26 Materstvedt L J, Kaasa S. The ethics of terminal sedation. http://www.medisin.ntnu.no/ims/kreft/slb/Dokument/Abstract/materstvedt_og_kaasa_Palermo_29_mars.pdf Poster 7th Congress of EAPC, Palermo 2001
• 27 Materstvedt L J, Clark D. et al . Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force.  Pall Medicine. 2003;  17 97-101
• 28 Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan.  J Pain Symp Manag. 1996;  12 32-38
• 29 Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: .  J Pain Symptom Manage. 2002;  24 447-453
• 30 Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death?.  J Palliat Care. 1999;  15 20-23
• 31 Morita T, Tsunoda J, Inoue S, Chihara S. Terminal sedation for existential distress.  Amer J Hosp Pall Care. 2000;  3 189-195
• 32 Müller-Busch H C. Zur Behandlung ethischer Probleme und Konflikte bei sterbenskranken und sterbenden Menschen.  Z Palliativmed. 2002;  3 70-77
• 33 Muller-Busch H C, Jehser T, Andres I. Sedation in palliative care - a critical analysis of 7 years experience.  BMC Palliat Care. 2003;  2 2
• 34 Müller-Busch H C, Klaschik E, Oduncu F S, SchindlerT, Woskanjan S. Euthanasie bei unerträglichem Leid: Eine Studie der Deutschen Gesellschaft für Palliativmedizin zum Thema Sterbehilfe im Jahre 2002.  Z Palliativmed. 2003;  4 75-84
• 35 Nunez-Olarte J M, Guillen D G. Cultural issues and ethical dilemmas in palliative and end-of- life care in Spain.  Cancer Control. 2001;  8 46-54
• 36 Ojeda-Martin M, Navarro-Marrero A, Gomez-Sancho M. Sedacion y enfermoa oncologico terminal.  Med Pal. 1997;  4 101-108
• 37 Orentlicher D. The Supreme Court and physician-assisted suicide - rejecting assisted suicide but embracing euthanasia. Sounding board.  N Engl J Med. 1997;  337 1236-1239
• 38 Porta-Sales J, Ylla-Català-Boré E, Estíbalez-Gil A. et al . Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos.  Med Pal. 1999;  6 153-158
• 39 Porta-Sales J. Sedation and terminal care.  EJPC. 2001;  8 97-100
• 40 Quill T E, Lo B, Brock D W. Palliative options of last resort. A comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia.  JAMA. 1997;  23 2099-104
• 41 Radbruch L. Reflections on the use of sedation in terminal care.  EJPC. 2002;  9 237-239
• 42 Ramsay M AE, Savege T M, Simpson B RJ, Goodwin R. Controlled sedation with alpaxalone-alphadolone.  Brit Med J. 1974;  2 656-659
• 43 Rousseau P. Existential suffering and palliative sedation: A brief commentary with a proposal for clinical guidelines.  Am J Hosp Pall Care. 2001;  18 151-153
• 44 Roy D. Need they sleep before they die?.  J Pall Care. 1990;  63 3-4
• 45 Steinhauser K E. et al . Factors considered important at the end of life by patients, family, physicians, and other care providers.  JAMA. 2000;  284 2476-2482
• 46 Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice.  Palliat Med. 1997;  11 140-14
• 47 Ventafridda V, Ripamonti C. et al . Symptom prevalence and control durino cancer patients last days of life.  J Pall Care. 1990;  6 7-11